Hengrui weighs Hong Kong IPO to drive the next phase of global expansion

Quick Summary:

A Hong Kong listing rarely boosts Chinese firms’ valuations, but Hengrui Pharmaceuticals might still take the plunge.

The post Hengrui weighs Hong Kong IPO to drive the next phase of global expansion appeared first on KrASIA.

However, a Hong Kong listing may not afford it the same advantage.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: 36Kr English

Category: TechnologyStartupsBusiness

Markets: ChinaHong Kong

Topics: International Listing Chinese Global Hong Hengrui Billion Pharmaceutical Company Kong Hengrui’s

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-10-31 @ 08:30:33 (4 days ago)

News Timezone: GMT +8:00

News Source URL: kr-asia.com

Language: English

Article Length: 141 words

Reading Time: 1 minutes read

Sentences: 44 lines

Sentence Length: 4 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © KrASIA

News ID: 23400191

View Article Analysis

About KrASIA

Main Topics: TechnologyStartupsBusiness

Official Website: kr-asia.com

Update Frequency: 2 posts per day

Year Established: 2017

Headquarters: China

News Last Updated: 20 hours ago

Coverage Areas: China

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #79

Publisher Details

Frequently Asked Questions